Bliss Biopharmaceutical (hangzhou) Co., Ltd

This early-stage trial is testing an experimental drug called BB-1709 in 300 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and look for early signs that it might shrink tumors. …